Cargando…
The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease
Autores principales: | Sinha, Smeeta, Chiu, Diana Y. Y., Peebles, George, Kolakkat, Shabeer, Lamerton, Elizabeth, Fenwick, Sean, Kalra, Philip A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421402/ https://www.ncbi.nlm.nih.gov/pubmed/25949371 http://dx.doi.org/10.1093/ndtplus/sfp073 |
Ejemplares similares
-
Dextran and Its Use in Colloidal Infusion Solutions
por: Shedd, Donald P.
Publicado: (1957) -
Iron infusion and newer intravenous iron formulations
por: Aung, Tim, et al.
Publicado: (2021) -
Accelerated Infliximab Infusion Safety and Tolerability Is Non-inferior to Standard Infusion Protocol in Inflammatory Bowel Disease Patients: A Randomized Controlled Study
por: Abushamma, Suha, et al.
Publicado: (2023) -
Intraventricular infusion of hyperosmolar dextran induces hydrocephalus: a novel animal model of hydrocephalus
por: Krishnamurthy, Satish, et al.
Publicado: (2009) -
Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion Reactions
por: Arastu, Asad H., et al.
Publicado: (2022)